Skip to main content
All lobbying filings

CURA STRATEGIES

Lobbying for PKD FOUNDATION · non-profit organization that funds and advocates for polycystic kidney disease research

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
Missouri

Official filing document

 Lobbyists on this filing 1
  • SCOTT C LEEZER
    Previously held: Aide to Senator Dick Durbin (D-IL)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Budget/Appropriations

Federal funding for PKD research at the National Institutes of Health (NIH).

Health Issues

Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).

Defense

Inclusion of PKD as a covered topic area under the Department of Defense's Peer Reviewed Medical Research Program (PRMRP).

 Bills named in this filing 4

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem